Management of pain in advanced disease

British Medical Bulletin

Volumn 110, Issue 1, 2014, Pages 117-128

  Harris, Dylan G ^a  

^a PRINCE CHARLES HOSPITAL   (United Kingdom)

Author keywords

Analgesic ladder; Cancer; Heart failure; Human immunodeficiency virus; Liver failure; Motor neurone disease; Multiple sclerosis; Pain; Palliative; Renal failure

Indexed keywords

ANALGESIC AGENT; BACLOFEN; DANTROLENE; FENTANYL; IBUPROFEN; MORPHINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; TIZANIDINE; TRAMADOL; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CODEINE; GABAPENTIN; HYDROMORPHONE; METHADONE; OPIATE; OXYCODONE; PREGABALIN; NARCOTIC ANALGESIC AGENT;

ARTICLE; BREAKTHROUGH PAIN; CANCER PAIN; CONSTIPATION; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; END STAGE RENAL DISEASE; GASTROINTESTINAL TOXICITY; HUMAN; HYPERALGESIA; LIVER DYSFUNCTION; NAUSEA; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; PAIN; PRIORITY JOURNAL; SEROTONIN SYNDROME; WEAKNESS; WORLD HEALTH ORGANIZATION; XEROSTOMIA; CLINICAL TRIAL; DRUG COST; DRUG MEGADOSE; EVIDENCE BASED PRACTICE; KIDNEY FAILURE; LIVER DISEASE; LOW DRUG DOSE; PRACTICE GUIDELINE; SPASTICITY; SYSTEMATIC REVIEW; ANALGESIA; DRUG ADMINISTRATION; KIDNEY; LIVER; PATHOPHYSIOLOGY; PROCEDURES; STANDARDS;

ANALGESICS, OPIOID; DRUG ADMINISTRATION SCHEDULE; HUMANS; KIDNEY; LIVER; PAIN; PAIN MANAGEMENT; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH ORGANIZATION;

EID: 84901987015     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldu010     Document Type: Article

References (51)

1. Merskey H, Bogduk N. Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms. AbeBooks [Online]. http://www. abebooks.com/9780931092053/Classification-Chronic-Pain-Descriptions- Syndromes-0931092051/plp (12 February 2014, date last accessed
2. Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: Evidencebased recommendations from the EAPC. Lancet Oncol 2012;13:e58-68
3. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31:58-69. (Pubitemid 43143299
4. Borsook D. Neurological diseases and pain. Brain J Neurol 2012;135(Pt 2):320-44
5. O'Connor AB, Schwid SR, Herrmann DN, et al. Pain associated with multiple sclerosis: Systematic review and proposed classification. Pain 2008;137:96-111. (Pubitemid 351794402
6. World Health Organisation. Cancer pain relief. Switzerland:World Health Organisation, 1986
7. World Health Organisation. WHO's cancer pain ladder for adults. WHO [Online]. http://www.who.int/cancer/ palliative/painladder/en/ (12 February 2014, date last accessed
8. Azevedo São Leão Ferreira K, Kimura M, Jacobsen Teixeira M. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it?. Support Care Cancer 2006;14:1086-93
9. Watson M, Lucas C, Hoy A, et al. Palliative Adult Network Guidelines. 3rd edn. UK: Tricord Limited, 2011 [Online]. http://book.pallcare.info/index.php (30 April 2014, date last accessed
10. Twycross RG,Wilcock A. Palliative Care Formulary. 4th edn. Nottingham, UK: Palliativedrugs.com Ltd, 2012
11. Nnoaham KE, Kumbang J. Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database Syst Rev 2008;CD003222
12. Paley CA, Tashani OA, Bagnall A-M, et al. A Cochrane systematic review of acupuncture for cancer pain in adults. BMJ Support Palliat Care 2011;1:51-5
13. Richmond C. Obituary: Dame Cicely Saunders. BMJ 2005;331:238
14. Caraceni A, Pigni A, Brunelli C. Is oral morphine still the first choice opioid for moderate to severe cancer pain?. A systematic review within the European Palliative Care Research Collaborative guidelines project. Palliat Med 2011;25:402-9
15. Harris D, Noble S. A practical approach to symptom management in palliative care. Br J HospMed 2006;67:404-8. (Pubitemid 44238089
16. Dickman A. Drugs in Palliative Care. Oxford, New York: Oxford University Press, 2012
17. Bnf: March 2014-September 2014. London: British Medical Assn, 2014
18. NICE. Neuropathic pain - pharmacological management [Online]. http://publications.nice.org.uk/neuropathic-painpharmacological-management- cg173. (12 February 2014, date last accessed
19. Klepstad P, Kaasa S, Borchgrevink PC. Starting step III opioids for moderate to severe pain in cancer patients: Dose titration: A systematic review. Palliat Med 2011;25: 424-30
20. Taubert M, Ross JR, Prettyjohns M, et al. Opioids in palliative care: Is the new NICE guideline relevant to specialist palliative care providers?. BMJ Support Palliat Care 2012. Bmjspcare-2012-000313
21. NICE. CG140 Opioids in palliative care: NICE guideline [Online]. http://publications.nice.org.uk/opioids-in-palliativecare-safe-And-effective- prescribing-of-strong-opioids-forpain-in-palliative-cg140 (5 February 2014, date last accessed
22. www mhra gov uk. Medicines and Healthcare products Regulatory Agency (MHRA). Fentanyl patches: Serious and fatal overdose from dosing errors, accidental exposure, and inappropriate use [Online]. http://www.mhra. gov.uk/Safetyinformation/DrugSafetyUpdate/CON087796 (5 April 2014, date last accessed
23. Tassinari D, Drudi F, Rosati M, et al. The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain: A systematic review. Palliat Med 2011;25:410-23
24. Nabal M, Librada S, Redondo MJ, et al. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med 2012;26:305-12
25. Stockler M, Vardy J, Pillai A, et al. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: A randomized, double-blind, placebocontrolled cross-over trial. J Clin Oncol 2004;22: 3389-94. (Pubitemid 41103698
26. Abstracts of the 7th World Research Congress of the European Association for Palliative Care (EAPC). Palliat Med 2012;26:384-674
27. Dale O, Moksnes K, Kaasa S. European Palliative Care Research Collaborative pain guidelines: Opioid switching to improve analgesia or reduce side effects. A systematic review. Palliat Med 2011;25:494-503
28. Mercadante S, Caraceni A. Conversion ratios for opioid switching in the treatment of cancer pain: A systematic review. Palliat Med 2011;25:504-15
29. Zeppetella G. Opioids for the management of breakthrough cancer pain in adults: A systematic review undertaken as part of an EPCRC opioid guidelines project. Palliat Med 2011;25:516-24
30. Chambers WA. Nerve blocks in palliative care. Br J Anaesth 2008;101:95-100
31. Christo PJ, Mazloomdoost D. Interventional pain treatments for cancer pain. Ann N Y Acad Sci 2008;1138:299-328
32. Lee M, Silverman SM, Hansen H, et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011;14:145-61
33. Zylicz Z, Twycross R. Opioid-induced hyperalgesia may be more frequent than previously thought. J Clin Oncol 2008;26:1564
34. King S, Forbes K, Hanks GW, et al. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: A European Palliative Care Research Collaborative opioid guidelines project. Palliat Med 2011;25:525-52
35. Harris D. Pain management in patients with renal impairment. Eur J Palliat Care 2008;15:214-6
36. Kimbell B, Murray SA. What is the patient experience in advanced liver disease?. A scoping review of the literature. BMJ Support Palliat Care 2013;bmjspcare-2012-000435
37. Chandok N, Watt KDS. Pain management in the cirrhotic patient: The clinical challenge. Mayo Clin Proc 2010;85:451-8
38. Tegeder I, Lötsch J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 1999;37:17-40
39. Hanna M. The effects of liver impairment on opioids used to relieve pain in cancer patients. Palliat Med 2011;25:604-5
40. Amarapurkar DN. Prescribing medications in patients with decompensated liver cirrhosis. Int J Hepatol 2011;2011:1-5
41. Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 2008;64:1147-61
42. Lewis JH, Stine JG. Review article: Prescribing medications in patients with cirrhosis - A practical guide. Aliment Pharmacol Ther 2013;37:1132-56
43. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: A systematic review. J Pain Symptom Manage 2004;28:140-75. (Pubitemid 38970077
44. Solaro C, Messmer Uccelli M. Pharmacological management of pain in patients with multiple sclerosis. Drugs 2010;70:1245-54
45. Bagshaw SM, Hagen NA. Medical efficacy of cannabinoids and marijuana: A comprehensive review of the literature. J Palliat Care 2002;18:111-22
46. Freynhagen R, Bennett MI. Diagnosis and management of neuropathic pain. BMJ 2009;339:b3002
47. Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: Systematic review. Palliat Med 2011;25: 553-9
48. NICE. Neuropathic pain - pharmacological management [Online]. http://publications.nice.org.uk/neuropathicpain-pharmacological-management- cg173. (12 February 2014, date last accessed
49. Zwakhalen SM, Hamers JP, Abu-Saad HH, et al. Pain in elderly people with severe dementia: A systematic review of behavioural pain assessment tools. BMC Geriatr 2006;6:3
50. Herr K, Bjoro K, Decker S. Tools for assessment of pain in nonverbal older adults with dementia: A state-of-Thescience review. J Pain SymptomManage 2006;31:170-92. (Pubitemid 43243669
51. Jordan A, Regnard C, O'Brien JT, et al. Pain and distress in advanced dementia: Choosing the right tools for the job. Palliat Med 2012;26:873-8